Clinical Trials Browser

Phase 1 × Leukemia, Promyelocytic, Acute × vadastuximab talirine × Clear all

NCT01902329 2018-01-05

A Safety Study of SGN-CD33A in AML Patients

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute